Cargando...

Personalized Cancer Medicine: Are We There Yet?

Personalized cancer medicine is at a crucial phase of development. This month's edition focuses on how innovation and the development of personalized medicine can positively influence disease outcomes–but at what price?

Guardado en:
Detalles Bibliográficos
Autores principales: Lawler, Mark, Selby, Peter
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063386/
https://ncbi.nlm.nih.gov/pubmed/23814159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0189
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!